Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,962 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06514339RecruitingEarly Phase 1
Shenhuang granules for sepsis treatment
This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.
Hangzhou, ZhejiangAges 18 years+ - NCT06514508RecruitingPhase 3
Stem cell collection with motixafortide and G-CSF for multiple myeloma
This trial tests a new drug, motixafortide, combined with a standard growth factor (G-CSF) to help collect stem cells for a transplant in people with multiple myeloma. It may be a good option if your myeloma is in remission and you have not had a stem cell transplant before.
Beijing, Beijing MunicipalityAges 18–78 - NCT06514573Recruiting
Butyrate supplement for children with autism and stomach issues
This study tests if a supplement called butyrate can help improve gut health in children aged 3-6 who have autism and ongoing stomach problems like constipation or bloating. It aims to see if this treatment eases their digestive symptoms.
NaplesAges 3–6 - NCT06515184RecruitingPhase 3
Coenzyme Q10 for Gulf War illness study
This study tests whether coenzyme Q10 (a natural supplement) can improve symptoms of Gulf War illness, such as fatigue and body pain. It involves taking the supplement or placebo for several months, with regular check-ins via Zoom and a few blood draws at a local lab.
La Jolla, CaliforniaAges 50 years+ - NCT06515210Recruiting
Fibre supplement for ulcerative colitis inflammation
This study tests whether a special fibre supplement can reduce inflammation in people with active ulcerative colitis. You take the supplement daily for a few weeks, and researchers check how it affects your symptoms and gut health.
Edmonton, AlbertaAges 14 years+ - NCT06515717Recruiting
Exogenous ketones and their effect on behavior
This study tests whether a drink containing ketone esters affects how people think and behave. It's for healthy, active adults who are not on any regular medication and have no major health conditions. You must also speak German fluently.
Potsdam, BrandenburgAges 18–45 - NCT06518603RecruitingPhase 4
Caffeine for preventing apnea in preterm babies in Zambia
This trial tests whether giving caffeine citrate can help prevent breathing pauses (apnea) in preterm babies who are ready to stop their current caffeine treatment. It aims to see if a short course of caffeine can keep babies stable after they come off oxygen and are eating well.
Lusaka, Lusaka ProvinceAges birth–1 year - NCT06520878RecruitingPhase 2
Nano-PSO for memory loss in older adults
This trial tests a supplement called NANO-PSO to see if it can help thinking and memory in older adults with mild to moderate memory problems. It may be an option for people with early Alzheimer's disease.
Miguel Hidalgo, Mexico CityAges 60 years+ - NCT06521476RecruitingPhase 2
Acetazolamide for sleep apnea in people on opioid treatment
This trial tests if a drug called acetazolamide can help people with central sleep apnea who are also on medication for opioid use disorder. Sleep apnea causes breathing to stop during sleep, and this study aims to see if the drug improves their sleep breathing.
Pittsburgh, PennsylvaniaAges 18–100 - NCT06524830RecruitingPhase 2
Testing VLS-01 film for treatment-resistant depression
This trial tests an experimental film placed inside the cheek (VLS-01) against a placebo to see if it helps people whose depression hasn't improved with standard antidepressants. If you have tried at least two antidepressants without success, this study may be an option for you.
Tucson, ArizonaAges 18–65 - NCT06525168RecruitingPhase 1
Safety study of DA414 in healthy volunteers
This trial tests a new medicine called DA414 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.
Wuhan, Hubei.ChinaAges 18–45 - NCT06525597RecruitingPhase 2
Stapokibart injection for allergic rhinitis
Stapokibart is a new injection that works on a key pathway involved in allergy symptoms. This study will test if this once-every-two-week shot can help reduce runny nose, sneezing, and itchy eyes in people with allergic rhinitis (hay fever).
Beijing, Beijing MunicipalityAges 12–65 - NCT06527222RecruitingPhase 2
Ranolazine for muscle cramps in ALS
This trial tests if a heart medication called ranolazine can reduce painful muscle cramps in people with ALS. If you experience frequent cramps and meet the other criteria, this study may be an option for you.
San Francisco, CaliforniaAges 18 years+ - NCT06527248Recruiting
Nitrate, exercise and blood vessel health in midlife women
This study looks at whether a natural compound in vegetables (called nitrate) combined with exercise can help improve blood vessel health in women after menopause. It may be a good fit if you are 45-65, do not exercise much, and have normal or mildly high blood pressure.
Vienna, State of ViennaAges 45–65 - NCT06527326Recruiting
Gut bacteria and central serous chorioretinopathy study
This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.
Hanzhou, ZhejiangAges Any age - NCT06528262RecruitingPhase 4
Study of enavogliflozin to prevent atrial fibrillation return after heart ablation
This trial tests if enavogliflozin, a diabetes drug, can help prevent atrial fibrillation (an irregular heartbeat) from coming back after a catheter ablation procedure in people with heart failure. If you've recently had or are planning this procedure, this study may offer a new way to keep your heart rhythm steady.
SeoulAges 19–84 - NCT06528444RecruitingPhase 3
Dexamethasone vs placebo for severe flu patients
This trial tests whether dexamethasone (a steroid) can help people hospitalized with severe flu recover faster. It is for adults who are already taking Tamiflu and do not have other serious infections like COVID-19.
AlicanteAges 18–100 - NCT06529692Recruiting
Split-belt treadmill training after ACL reconstruction
This study tests whether walking on a special split-belt treadmill (where each belt moves at a different speed) can help improve how your knee moves and feels after ACL reconstruction. The goal is to see if this training leads to better long-term knee health.
Ann Arbor, MichiganAges 14–45 - NCT06530290RecruitingPhase 2
Mirtazapine for anxiety in Parkinson's disease
This trial tests whether mirtazapine, a medication often used for depression and anxiety, can reduce anxiety symptoms in people with Parkinson's disease. It is for patients with mild to moderate Parkinson's who also experience anxiety.
TehranAges 18 years+ - NCT06532526Recruiting
Tooth sensitivity treatment during teeth whitening
This study tests whether a special desensitizing gel can reduce tooth sensitivity caused by professional teeth whitening. If you are a smoker between 18 and 30 with dark anterior teeth wanting whiter teeth, this may help you experience less discomfort.
IrbidAges 18–35 - NCT06532942RecruitingPhase 1
Safety study of an inhaled drug in healthy adults
This study tests a new inhaled drug (MKND-201) in healthy volunteers to see if it's safe and how the body processes it. If you are a generally healthy adult between 40 and 65, you might be able to help researchers understand if this medicine is safe for future studies.
San Antonio, TexasAges 40–65 - NCT06533137Recruiting
How your mind can influence the placebo effect
This trial studies how your awareness and personal beliefs affect the placebo effect—a real improvement in symptoms from a treatment that has no active medicine. Researchers are looking at healthy people to understand how the mind and body interact, which could help improve future treatments.
MilanAges 18 years+ - NCT06534723RecruitingPhase 3
Wujia Yizhi granules for mild-to-moderate Alzheimer's
This trial tests if a Chinese herbal granule (Wujia Yizhi) can help people with mild-to-moderate Alzheimer's dementia. It is for patients who have memory problems for at least 6 months and meet specific Alzheimer's biomarker criteria.
Fuzhou, FujianAges 50–80 - NCT06535308RecruitingPhase 1
Testing a new Alzheimer's drug for moderate disease
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
Seoul, Jongno-guAges 19–45
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,962 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.